Millennium Capital Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,075
Closed -$322K 122
2023
Q4
$322K Sell
4,075
-2,525
-38% -$180K 0.25% 73
2023
Q3
$461K Sell
6,600
-1,600
-20% -$113K 0.39% 54
2023
Q2
$567K Sell
8,200
-670
-8% -$47.7K 0.47% 48
2023
Q1
$659K Buy
8,870
+696
+9% +$58.4K 0.59% 45
2022
Q4
$762K Sell
8,174
-600
-7% -$57.9K 0.77% 39
2022
Q3
$837K Sell
8,774
-950
-10% -$94K 0.88% 32
2022
Q2
$901K Sell
9,724
-370
-4% -$36.1K 0.88% 31
2022
Q1
$1.02M Sell
10,094
-205
-2% -$21.5K 0.82% 29
2021
Q4
$1.06M Buy
+10,299
New +$952K 0.83% 27

Other funds holding CVS

Millennium Capital Advisors's CVS Position: Q1 2024 in Review

Millennium Capital Advisors sold out of CVS Health (CVS) in Q1 2024, closing a stake of 4,075 shares — an estimated $322K sold.

Millennium Capital Advisors first reported a position in CVS in Q4 2021 and held it in 9 quarters. The position peaked at $1.06M in Q4 2021. 2,181 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Millennium Capital Advisors reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Millennium Capital Advisors sold 4,075 CVS Health shares in Q1 2024, an estimated $322K.
  • Millennium Capital Advisors first reported a position in CVS Health in Q4 2021 and held it in 9 quarters.
  • Millennium Capital Advisors's CVS Health position peaked at $1.06M in Q4 2021.
  • 2,181 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Millennium Capital Advisors's 13F filing for Q1 2024, filed 18 Feb 2026.